1269 related articles for article (PubMed ID: 20577053)
1. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
2. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
3. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
5. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
7. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
8. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
9. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
Bang S; Chen Y; Ahima RS; Kim SF
Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
11. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
Takashima M; Ogawa W; Hayashi K; Inoue H; Kinoshita S; Okamoto Y; Sakaue H; Wataoka Y; Emi A; Senga Y; Matsuki Y; Watanabe E; Hiramatsu R; Kasuga M
Diabetes; 2010 Jul; 59(7):1608-15. PubMed ID: 20393151
[TBL] [Abstract][Full Text] [Related]
12. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
13. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.
Aatsinki SM; Buler M; Salomäki H; Koulu M; Pavek P; Hakkola J
Br J Pharmacol; 2014 May; 171(9):2351-63. PubMed ID: 24428821
[TBL] [Abstract][Full Text] [Related]
14. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
Yuan HD; Piao GC
Biosci Biotechnol Biochem; 2011; 75(6):1079-84. PubMed ID: 21670525
[TBL] [Abstract][Full Text] [Related]
15. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
16. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Phloroglucinol, A Component of Ecklonia cava Extract, on Hepatic Glucose Production.
Yoon JY; Choi H; Jun HS
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28379184
[TBL] [Abstract][Full Text] [Related]
18. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
[TBL] [Abstract][Full Text] [Related]
19. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
[TBL] [Abstract][Full Text] [Related]
20. Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
Chanda D; Kim SJ; Lee IK; Shong M; Choi HS
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E368-79. PubMed ID: 18505831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
